Metformin: Drug of choice for the prevention of type 2 diabetes and cardiovascular complications in high-risk subjects

Diabetes and Metabolism

Volumn 29, Issue 4 II, 2003, Pages

  Standl, Eberhard ^a  

^a NONE   (Germany)

Author keywords

Cardiovascular disease; Metformin; Type 2 diabetes

Indexed keywords

METFORMIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE CONTROL; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PROPHYLAXIS; REVIEW; RISK FACTOR;

EID: 17944386520     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1262-3636(03)72797-9     Document Type: Review

References (2)

1. Standl E, Schnell O. A new look at the heart in diabetes mellitus: from ailing to failing. Diabetologia, 2000, 43, 1455-69.
2. Rihl J, Biermann E, Standl E. Insulin resistance and type 2 diabetes: the IRIS Study. Diabetes & Stoffw, 2002, 11, 150-8.